You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -5.8 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 0.0 | n/a |
Price / Book value | 14.5 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-06-30 | 0.05 | -1.12 | -1.50p | -17.5 | 0.0 | n/a | n/a | 0.0% |
2021-06-30 | n/a | -1.72 | -2.30p | -125.0 | 0.0 | n/a | n/a | 0.0% |
2022-06-30 | n/a | 2.58 | -3.20p | -63.3 | 0.0 | n/a | n/a | 0.0% |
2023-06-30 | n/a | -4.03 | -4.70p | -26.6 | 0.0 | n/a | n/a | 0.0% |
2024-06-30 | n/a | -4.60 | -4.20p | -10.6 | 0.0 | n/a | n/a | 0.0% |
Sareum shares rise on China patent allowance Sharecast News | 16 Sep |
---|---|
Sareum granted US patent on autoimmune therapeutic candidate Sharecast News | 02 Sep |
Sareum announces positive results from kinase inhibitor trial Sharecast News | 01 Jul |
Final Results for the Year Ended 30 June 2024 | 29-Oct-24 07:01 |
---|---|
Notice of Final Results and Investor Presentation | 23-Oct-24 07:01 |
Further Subscription to raise £1,000,000 | 21-Oct-24 07:01 |
Subscription to raise £2,364,000 | 11-Oct-24 07:01 |
Patent Allowance in China | 16-Sep-24 07:52 |